Under construction – not a live service

Skip to content

Frontlight Research

Trial site

I.U.C.T Oncopole

Toulouse, 31100, FranceNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Mantle cell lymphoma

Closed trials

Completed
Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven Maintenance
NCT02896582· Phase 2· The Lymphoma Academic Research Organisation· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – I.U.C.T Oncopole: trial site – Frontlight Research